Creation of myocardial fibrosis by transplantation of fibroblasts primed with survival factors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Lee, Dong Won ^a   Lee, Tae Kyu ^a   Cho, Ik Sung ^a   Park, Hyo Eun ^a   Jin, Sooryeonhwa ^a   Cho, Hyun Jai ^a   Kim, Soon Ha ^b   Oh, Seil ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b LG Chemical Ltd   (South Korea)

Author keywords

Cell engraftment; Cell survival; Necrosis inhibition

Indexed keywords

BETA GALACTOSIDASE; PROTEIN KINASE B;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL ISOLATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THORACOTOMY; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEART CONDUCTION SYSTEM; HEART DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; NECROSIS; NIH 3T3 CELLS; ORGANIC CHEMICALS; PROTO-ONCOGENE PROTEINS C-AKT; TIME FACTORS; TRANSFECTION;

EID: 80052307580     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00156.2011     Document Type: Article

References (33)

1. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291: H1015-H1026, 2006.
2. AE, de Groot NM, van Erven L, Bootsma M, van der Wall EE, Schalij MJ. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach? J Cardiovasc Electrophysiol 13: 417-423, 2002.
3. Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, Wang XL, Lee HC, Caplice NM, Packer DL. Impact of transforming growth factor-1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation 113: 2485-2494, 2006.
4. Cho HJ, Youn SW, Cheon SI, Kim TY, Hur J, Zhang SY, Lee SP, Park KW, Lee MM, Choi YS, Park YB, Kim HS. Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase. Arterioscler Thromb Vasc Biol 25: 1154-1160, 2005.
5. Choi JM, Park KM, Hwang DW, Chon SH, Kim SH, Lee YJ. Effect of necrosis modulator NecroX-7 on hepatic ischemia-reperfusion injury in beagle dogs. Transpl Proc 34: 3414-3421, 2010.
6. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
7. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
8. Haidara K, Morel I, Abalea V, Gascon Barre M, Denizeau F. Mechanism of tert-butylhydroperoxide induced apoptosis in rat hepatocytes: involvement of mitochondria and endoplasmic reticulum. Biochim Biophys Acta 1542: 173-185, 2002.
9. Hur J, Yoon CH, Lee CS, Kim TY, Oh IY, Park KW, Kim JH, Lee HS, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25: 1769-1778, 2007.
10. Jennings RB, Reimer KA, Steenbergen C. Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol 18: 769-780, 1986.
11. Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, Pani P, Santacroce S, Simone S, Bucci R, Farber E. Cell death: apoptosis versus necrosis. Int J Oncol 21: 165-170, 2002.
12. Kim HJ, Koo SY, Ahn BH, Park O, Park DH, Seo DO, Won JH, Yim HJ, Kwak HS, Park HS, Chung CW, Oh YL, Kim SH. NecroX as a novel class of mitochondrial reactive oxygen species and ONOO scavenger. Arch Pharmacol Res (Seoul) 33: 1813-1823, 2010.
13. Kim JY, Cho HJ, Sir JJ, Kim BK, Hur J, Youn SW, Yang HM, Jun SI, Park KW, Hwang SJ, Kwon YW, Lee HY, Kang HJ, Oh BH, Park YB, Kim HS. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia. Cardiovasc Res 82: 550-560, 2009.
14. Koh YJ, Koh BI, Kim H, Joo HJ, Jin HK, Jeon J, Choi C, Lee DH, Chung JH, Cho CH, Park WS, Ryu JK, Suh JK, Koh GY. Stromal vascular fraction from adipose tissue forms profound vascular network through the dynamic reassembly of blood endothelial cells. Arterioscler Thromb Vasc Biol 31: 1141-1150, 2011.
15. Lee ST, Chu K, Kim EH, Jung KH, Lee KB, Sinn DI, Kim SU, Kim M, Roh JK. Quantification of human neural stem cell engraftments in rat brains using ERV-3 real-time PCR. J Neurosci Methods 157: 225-229, 2006.
16. Lin CF, Chen CL, Chang WT, Jan MS, Hsu LJ, Wu RH, Fang YT, Tang MJ, Chang WC, Lin YS. Bcl-2 rescues ceramide-and etoposideinduced mitochondrial apoptosis through blockage of caspase-2 activation. J Biol Chem 280: 23758-23765, 2005.
17. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-B. Mol Cell Biol 20: 1626-1638, 2000.
18. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201, 2003.
19. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996.
20. Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, Fleischmann BK, Hescheler J, Schwinger RH. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41: 876-884, 2006.
21. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34: 107-116, 2002.
22. Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res 102: 1471-1482, 2008.
23. Phan SH. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 5: 334-337, 2008.
24. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West Myofibroblasts AB I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 277: C1-C9, 1999.
25. Reddig PJ, Juliano RL. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24: 425-439, 2005.
26. Robey TE, Saiget MK, Reinecke H, Murry CE. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581, 2008.
27. Sen L, Hong YS, Luo H, Cui G, Laks H. Efficiency, efficacy, and adverse effects of adenovirus vs. liposome-mediated gene therapy in cardiac allografts. Am J Physiol Heart Circ Physiol 281: H1433-H1441, 2001.
28. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-B and Bad. J Am Soc Nephrol 14: 1427-1434, 2003.
29. Subramanian SV, Kelm RJ, Polikandriotis JA, Orosz CG, Strauch AR. Reprogramming of vascular smooth muscle-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc Res 54: 539-548, 2002.
30. Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH. Role of interleukin-1 in acute inflammation and graft death after cell transplantation to the heart. Circulation 110: II219-II224, 2004.
31. Wong T, McGrath JA, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 156: 1149-1155, 2007.
32. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921, 2001.
33. Zvibel I, Smets F, Soriano H. Anoikis: roadblock to cell transplantation? Cell Transplant 11: 621-630, 2002.